부산대학교 도서관

Volk JE; Hessol NA; Gray GE; Kublin JG; Churchyard G; Mlisana K; Nchabeleng M; Buchbinder SP; Bekker L

Retrovirology, Vol 9, Iss Suppl 2, p P131 (2012)

Zhang B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Fintzi J; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Chu E; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Kenny A; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Carone M; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Benkeser D; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.; van der Laan LWP; Department of Statistics, University of Washington, Seattle, WA, USA.; Deng W; Moderna, Inc, Cambridge, MA, USA.; Zhou H; Moderna, Inc, Cambridge, MA, USA.; Wang X; Moderna, Inc, Cambridge, MA, USA.; Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Borate B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Chen H; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Reeder I; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Houchens CR; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Martins K; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Jayashankar L; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Huynh C; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Fichtenbaum CJ; Division of Infectious Diseases, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA.; Kalams S; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.; Gay CL; Department of Medicine, Division of Infectious Diseases, UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Andrasik MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.; Priddy F; Moderna, Inc, Cambridge, MA, USA.; Das R; Moderna, Inc, Cambridge, MA, USA.; Girard B; Moderna, Inc, Cambridge, MA, USA.; El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.; Baden LR; Brigham and Women's Hospital, Boston, MA, USA.; Jones T; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Donis RO; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. dfollmann@niaid.nih.gov.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Kenny A; Department of Biostatistics, University of Washington, Seattle, WA, USA.; van Duijn J; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; Dintwe O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Heptinstall J; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; Burnham R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Sawant S; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; Zhang L; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; Mielke D; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.; Khuzwayo S; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Omar FL; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Stanfield-Oakley S; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.; Keyes T; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.; Dunn B; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.; Goodman D; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Benkeser D; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.; Zou R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Luedtke A; Department of Statistics, University of Washington, Seattle, WA, USA.; van der Laan L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Statistics, University of Washington, Seattle, WA, USA.; Giorgi EE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Magaret C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Pattacini L; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; van de Kerkhof T; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; Korber B; Los Alamos National Laboratory, Los Alamos, NM, USA; New Mexico Consortium, Los Alamos, NM, USA.; Willems W; Janssen Research & Development BE, Beerse, Belgium.; Fisher LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Schuitemaker H; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; Swann E; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Pau MG; Janssen Infectious Diseases BV, Beerse, Belgium.; Buchbinder S; San Francisco Department of Public Health, San Francisco, CA, USA.; Tomaka F; Janssen Research & Development, LLC, Titusville, NJ, USA.; Nijs S; Janssen Infectious Diseases BV, Beerse, Belgium.; Lavreys L; Janssen Infectious Diseases BV, Beerse, Belgium.; Gelderblom HC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, 98195, USA.; Mngadi K; The Aurum Institute, Johannesburg, South Africa.; Gray GE; South African Medical Research Council, Cape Town, South Africa.; Borducchi E; Center for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Hendriks J; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; Seaton KE; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; Zolla-Pazner S; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Barouch DH; Center for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA.; Ferrari G; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Stieh DJ; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; Tomaras GD; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA; Department of Integrative Immunobiology, Duke University, Durham, NC, USA. Electronic address: georgia.tomaras@duke.edu.; Gilbert PB; Department of Biostatistics, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: pgilbert@fredhutch.org.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

Janes H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Fisher LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Parameswaran L; New York University Langone Vaccine Center, New York University Grossman School of Medicine, New York, New York, USA.; Goepfert PA; Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Falsey AR; Infectious Disease Division, University of Rochester, Rochester, New York, USA.; Ludwig J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Rouphael N; Hope Clinic, Emory University, Atlanta, Georgia, USA.; Sobieszczyk ME; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.; El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.; Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Gray GE; South African Medical Research Council, Cape Town, South Africa.; Kotloff KL; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Gay CL; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Greninger AL; Department of Medicine, Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA.; Tapia MD; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Hammershaimb EA; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Priddy FH; Moderna, Inc, Cambridge, Massachusetts, USA.; Green JA; Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom.; Struyf F; Janssen Research and Development, Beerse, Belgium.; Dunkle L; Novavax, Inc, Gaithersburg, Maryland, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

Church EC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Seattle-King County Public Health, Seattle, WA.; Bishop E; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Yu KKQ; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Chang M; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA.; Jones RM; Department of Microbiology, University of Washington School of Medicine, Seattle, WA.; Brache JK; Department of Microbiology, University of Washington School of Medicine, Seattle, WA.; Ballweber Fleming L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Phan JM; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Makatsa MS; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Heptinstall J; Duke Center for Human Systems Immunology, Duke University, Durham, NC.; Chiong K; Duke Center for Human Systems Immunology, Duke University, Durham, NC.; Dintwe O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Naidoo A; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Voillet V; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Mayer-Blackwell K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Nwanne G; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Vary JC Jr; Department of Dermatology, University of Washington School of Medicine, Seattle, WA.; Tomaras GD; Duke Center for Human Systems Immunology, Duke University, Durham, NC.; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Sherman DR; Department of Microbiology, University of Washington School of Medicine, Seattle, WA.; Murphy SC; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Seshadri C; Department of Medicine, University of Washington School of Medicine, Seattle, WA.

Publisher: American Association of Immunologists, Inc Country of Publication: United States NLM ID: 101708159 Publication Model: Print Cited Medium: Internet ISSN: 2573-7732 (Electronic) Linking ISSN: 25737732 NLM ISO Abbreviation: Immunohorizons Subsets: MEDLINE

Balasingam S; Infectious Disease, Wellcome Trust, London, United Kingdom.; Dheda K; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and University of Cape Town (UCT) Lung Institute and South African Medical Research Council/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, South Africa.; Fortune S; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Gordon SB; Clinical Experimental Medicine, Malawi Liverpool Wellcome Programme, Blantyre.; Hoft D; Departments of Internal Medicine and Molecular Microbiology & Immunology, Saint Louis University of Medicine, Missouri.; Kublin JG; Cancer Center, Vaccine and Infectious Disease Division, Fred Hutchinson Institute, Seattle, Washington.; Loynachan CN; Infectious Disease, Wellcome Trust, London, United Kingdom.; McShane H; The Jenner Institute, University of Oxford, United Kingdom.; Morton B; Department of Clinical Sciences, Liverpool School of Tropical Medicine, United Kingdom.; Nambiar S; TB Impact Area, International AIDS Vaccine Initiative, New York, New York.; Sharma NR; Infectious Disease, Wellcome Trust, London, United Kingdom.; Robertson B; Department of Infectious Disease, Imperial College London, United Kingdom.; Schrager LK; TB Impact Area, International AIDS Vaccine Initiative, New York, New York.; Weller CL; Infectious Disease, Wellcome Trust, London, United Kingdom.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

Sherman AC; Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Tuan J; Yale School of Medicine, Section of Infectious Diseases, New Haven, Connecticut, USA.; Cantos VD; Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA.; Adeyiga O; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California, USA.; Mahoney S; Department of Medicine, University of Cape Town, Desmond Tutu HIV Centre, Cape Town, South Africa.; Ortega-Villa AM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Tillman A; Frederick National Laboratory for Cancer Research, Clinical Monitoring Research Program Directorate, Frederick, Maryland, USA.; Whitaker J; Department of Molecular Virology and Microbiology and Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Woodward Davis AS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Leav B; Moderna Inc., Cambridge, Massachusetts, USA.; Hirsch I; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Sadoff J; Janssen Vaccines and Prevention, Leiden, Netherlands.; Dunkle LM; Novavax, Gaithersburg, Maryland, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Goepfert PA; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Kotloff K; Department of Pediatrics and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Rouphael N; Hope Clinic, Emory University, Atlanta, Georgia, USA.; Falsey AR; Infectious Disease Division, University of Rochester, Rochester, New York, USA.; El Sahly HM; Department of Molecular Virology and Microbiology and Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Sobieszczyk ME; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; Grinsztejn B; National Institute of Infectious Diseases-Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Gray G; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South African Medical Research Council, Cape Town, South Africa.; Nason M; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Baden LR; Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Gay CL; Department of Medicine, Division of Infectious Diseases, UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Chihana R; Johns Hopkins Research Project, P.O Box 1131, Blantyre, Malawi. Electronic address: rkawalazira@jhp.mw.; Jin Kee J; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA.; Moodie Z; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA.; Huang Y; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA.; Janes H; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA.; Dadabhai S; Johns Hopkins Research Project, P.O Box 1131, Blantyre, Malawi.; Roxby AC; University of Washington, P.O Box 355852, WA 98195-5852, USA; Fred Hutchinson Cancer Center, P.O Box 19024, WA 98109-1024, Seattle, USA.; Allen M; National Institutes of Health, 9000, Rockville Pike, Bethesda, USA.; Kassim S; The Desmond Tutu HIV Centre, P.O Box 13801, Mowbray 7705, Cape Town, South Africa.; Naicker V; South Africa Medical Research Council, P.O Box 19070, Cape Town, South Africa.; Innes C; Aurum Institute, The Ridge, 29 Queens Road, Johannesburg, South Africa.; Naicker N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Private Bag X7, Durban, South Africa.; Dubula T; Walter Sisulu University, P. O Box 142, Eastern Cape, South Africa.; Grunenberg N; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA.; Malahleha M; Setshaba Research Centre, P.O Box 468, Pretoria, South Africa; Synergy Biomed Research Institute, 280 Oxford Street, East London 5201, South Africa.; Kublin JG; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA.; Bekker LG; The Desmond Tutu HIV Centre, P.O Box 13801, Mowbray 7705, Cape Town, South Africa.; Gray G; Perinatal HIV Research Unit, P.O Box 114, University of the Witwatersrand, South Africa.; Kumwenda J; Johns Hopkins Research Project, P.O Box 1131, Blantyre, Malawi.; Laher F; Perinatal HIV Research Unit, P.O Box 114, University of the Witwatersrand, South Africa.

Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

Garrett N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.; Dintwe O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cape Town HVTN Immunology Laboratory, Cape Town, South Africa.; Monaco CL; Department of Medicine, Division of Infectious Diseases, University of Rochester Medical Center, Rochester, NY.; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY.; Jones M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Seaton KE; Center for Human Systems Immunology, Departments of Surgery, Molecular Genetics and Microbiology, and Immunology, Duke University School of Medicine, Durham, NC.; Church EC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Hutter J; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; deCamp A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Lu H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Mann P; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Robinson ST; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Heptinstall J; Center for Human Systems Immunology, Departments of Surgery, Molecular Genetics and Microbiology, and Immunology, Duke University School of Medicine, Durham, NC.; Jensen RL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Pantaleo G; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.; Ding S; EuroVacc Foundation, Lausanne, Switzerland.; Koutsoukos M; GlaxoSmithKline, Wavre, Belgium.; Hosseinipour MC; University of North Carolina at Chapel Hill, Chapel Hill, NC.; UNC Project-Malawi, Lilongwe, Malawi.; Van Der Meeren O; GlaxoSmithKline, Rixensart, Belgium ; and.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Ferrari G; Center for Human Systems Immunology, Departments of Surgery, Molecular Genetics and Microbiology, and Immunology, Duke University School of Medicine, Durham, NC.; Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cape Town HVTN Immunology Laboratory, Cape Town, South Africa.; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Tomaras GD; Center for Human Systems Immunology, Departments of Surgery, Molecular Genetics and Microbiology, and Immunology, Duke University School of Medicine, Durham, NC.; Gray GE; South African Medical Research Council, Tygerberg, South Africa .; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.

Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1944-7884 (Electronic) Linking ISSN: 15254135 NLM ISO Abbreviation: J Acquir Immune Defic Syndr Subsets: MEDLINE

Gray GE; South African Medical Research Council, Cape Town, South Africa. Electronic address: glenda.gray@mrc.ac.za.; Mngadi K; The Aurum Institute, Johannesburg, South Africa.; Lavreys L; Janssen Infectious Diseases, Beerse, Belgium.; Nijs S; Janssen Infectious Diseases, Beerse, Belgium.; Gilbert PB; Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Statistics, University of Washington, Seattle, WA, USA.; Hural J; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hyrien O; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Juraska M; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Luedtke A; Department of Statistics, University of Washington, Seattle, WA, USA.; Mann P; Fred Hutchinson Cancer Center, Seattle, WA, USA.; McElrath MJ; Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.; Odhiambo JA; Hutchinson Center Research Institute of South Africa, Cape Town, South Africa.; Stieh DJ; Janssen Vaccines & Prevention, Leiden, Netherlands.; van Duijn J; Janssen Vaccines & Prevention, Leiden, Netherlands.; Takalani AN; Hutchinson Center Research Institute of South Africa, Cape Town, South Africa.; Willems W; Janssen Research & Development, Beerse, Belgium.; Tapley A; Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.; Tomaras GD; Center for Human Systems Immunology, Duke University, Durham, NC, USA; Department of Surgery, Duke University, Durham, NC, USA; Department of Integrative Immunobiology, Duke University, Durham, NC, USA; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Van Hoof J; Janssen Vaccines & Prevention, Leiden, Netherlands.; Schuitemaker H; Janssen Vaccines & Prevention, Leiden, Netherlands.; Swann E; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.; Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA.; Kublin JG; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Corey L; Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Pau MG; Janssen Infectious Diseases, Beerse, Belgium.; Buchbinder S; San Francisco Department of Public Health, San Francisco, CA, USA.; Tomaka F; Janssen Research & Development, Titusville, NJ, USA.

Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE